Cargando…

The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation

BACKGROUND: This study investigated the clinicopathological features, immunophenotypic characteristics and differential diagnosis of primary breast carcinomas with signet ring cell differentiation, as well as differences in the traits of signet ring-like cell mucin. METHODS: A total of five cases of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jie, Liu, Junlin, Yang, Wan, Yao, Jia, Guo, Jiao, Liu, Changqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280868/
https://www.ncbi.nlm.nih.gov/pubmed/37337182
http://dx.doi.org/10.1186/s12957-023-03074-x
_version_ 1785060892359000064
author Zheng, Jie
Liu, Junlin
Yang, Wan
Yao, Jia
Guo, Jiao
Liu, Changqing
author_facet Zheng, Jie
Liu, Junlin
Yang, Wan
Yao, Jia
Guo, Jiao
Liu, Changqing
author_sort Zheng, Jie
collection PubMed
description BACKGROUND: This study investigated the clinicopathological features, immunophenotypic characteristics and differential diagnosis of primary breast carcinomas with signet ring cell differentiation, as well as differences in the traits of signet ring-like cell mucin. METHODS: A total of five cases of primary breast cancer diagnosed with signet ring cell differentiation and treated at The First People’s Hospital of Jingmen from January 2016 to December 2021 were collected. HE, immunohistochemical staining, and AB-PAS staining were used for the analysis. RESULTS: Although we strictly selected all the primary breast cancer cases with signet ring cell differentiation, there were differences in the arrangement of the cells and the grading of nuclei. Our immunohistochemical results showed that the ER was consistently strongly positive, and the PR expression was not consistent, while all the cases of HER2 were negative. CK7 was negative in one case, and CK20 and CK5/6 were not expressed in all the cases. The mucin MUC1 was positive and showed two patterns. MUC2 was strongly positive in all the cases. All the cases were negative for CDX2, SATB2, PAX8, TTF-1, and Napsin A, while the positive expression of COX2, Villin, and WT-1 was not constant. One case expressed neuroendocrine markers. The expression level of Ki67 was between 10 and 30%. AB (pH 2.5)-PAS staining revealed that the intracellular mucus contained more cells with neutral mucus, while the extracellular mucus was mainly acidic. CONCLUSION: We found that histological morphology, cell morphology, and nuclear grading differentiate among different cases. The immunohistochemical characteristics of primary breast cancers diagnosed with signet ring cell differentiation are helpful for identification. The differences in the expression patterns of mucins may be related to unfavorable clinicopathological factors, but their usefulness as a prognostic marker remains to be further understood. The heterogeneity of cell mucus, the differentiation of tumor cells, and the phenotypic changes of tumors also need further study.
format Online
Article
Text
id pubmed-10280868
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102808682023-06-21 The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation Zheng, Jie Liu, Junlin Yang, Wan Yao, Jia Guo, Jiao Liu, Changqing World J Surg Oncol Research BACKGROUND: This study investigated the clinicopathological features, immunophenotypic characteristics and differential diagnosis of primary breast carcinomas with signet ring cell differentiation, as well as differences in the traits of signet ring-like cell mucin. METHODS: A total of five cases of primary breast cancer diagnosed with signet ring cell differentiation and treated at The First People’s Hospital of Jingmen from January 2016 to December 2021 were collected. HE, immunohistochemical staining, and AB-PAS staining were used for the analysis. RESULTS: Although we strictly selected all the primary breast cancer cases with signet ring cell differentiation, there were differences in the arrangement of the cells and the grading of nuclei. Our immunohistochemical results showed that the ER was consistently strongly positive, and the PR expression was not consistent, while all the cases of HER2 were negative. CK7 was negative in one case, and CK20 and CK5/6 were not expressed in all the cases. The mucin MUC1 was positive and showed two patterns. MUC2 was strongly positive in all the cases. All the cases were negative for CDX2, SATB2, PAX8, TTF-1, and Napsin A, while the positive expression of COX2, Villin, and WT-1 was not constant. One case expressed neuroendocrine markers. The expression level of Ki67 was between 10 and 30%. AB (pH 2.5)-PAS staining revealed that the intracellular mucus contained more cells with neutral mucus, while the extracellular mucus was mainly acidic. CONCLUSION: We found that histological morphology, cell morphology, and nuclear grading differentiate among different cases. The immunohistochemical characteristics of primary breast cancers diagnosed with signet ring cell differentiation are helpful for identification. The differences in the expression patterns of mucins may be related to unfavorable clinicopathological factors, but their usefulness as a prognostic marker remains to be further understood. The heterogeneity of cell mucus, the differentiation of tumor cells, and the phenotypic changes of tumors also need further study. BioMed Central 2023-06-19 /pmc/articles/PMC10280868/ /pubmed/37337182 http://dx.doi.org/10.1186/s12957-023-03074-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zheng, Jie
Liu, Junlin
Yang, Wan
Yao, Jia
Guo, Jiao
Liu, Changqing
The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation
title The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation
title_full The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation
title_fullStr The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation
title_full_unstemmed The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation
title_short The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation
title_sort clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280868/
https://www.ncbi.nlm.nih.gov/pubmed/37337182
http://dx.doi.org/10.1186/s12957-023-03074-x
work_keys_str_mv AT zhengjie theclinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT liujunlin theclinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT yangwan theclinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT yaojia theclinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT guojiao theclinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT liuchangqing theclinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT zhengjie clinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT liujunlin clinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT yangwan clinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT yaojia clinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT guojiao clinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation
AT liuchangqing clinicopathologicalandimmunohistochemicalfeaturesofbreastcarcinomaswithsignetringcelldifferentiation